Venture Life sells Ultradex and Dentyl brands to focus on core business
LONDON — Venture Life Group, a global consumer healthcare company, announced Monday it has completed the sale of its Ultradex and Dentyl oral care brands to Covestus Holdings Ltd. for an enterprise value of up to 4.5 million pounds ($5.8 million). The deal includes 100% of the issued share capital of Periproducts Limited. Venture Life…